Skip to main content
. 2026 Feb 16;91(1):86. doi: 10.1007/s12020-025-04509-z

Table 2.

Comparison of mean capillary blood glucose and dose of insulin used in the two groups at the end of the study

Parameters App group (n = 43) Control group (n = 43) P
Days 7.0 (6.0, 7.0) 7.0 (6.0, 7.0) 0.271
Pre-breakfast CBG (mmol/L) (mmol/L) (mmol/L) 7.56 (6.94, 9.53) 8.26 (7.28, 9.65) 0.148
Pre-lunch CBG (mmol/L) 10.21 (8.58, 12.16) 11.17 (9.89, 14.86) 0.096
Pre-dinner CBG (mmol/L) 10.07 (8.70, 11.60) 11.42 (9.94, 14.46) 0.006
Pre-bedtime CBG (mmol/L) 9.93 (8.83, 11.33) 10.71 (9.62, 12.72) 0.039
Total insulin dose (U)(U) 230.0 (200.0, 293.0) 244.0 (172.0, 297.0) 0.972
Total insulin dose /weight (U/kg) 0.59 (0.47, 0.73) 0.57 (0.47, 0.74) 0.789
Average daily insulin dose (U/day) 37.0 (28.7, 46.4) 35.7 (31.9, 45.0) 0.675
Patients with CBG <3.9 mmol/L (N, %) 6 (14.0%) 9 (20.9%) 0.394
CGM-detected hypoglycemia(<3.9 mmol/L) (N) 2.0 (0, 3.0) 0 (0, 3.5) 0.152

CBG capillary blood glucose